ID   Tahr87
AC   CVCL_A398
SY   TAHR-87; Tahr-87; Tahr 87
DR   Cosmic; 999767
DR   Cosmic; 1281354
DR   Cosmic; 2491092
DR   Wikidata; Q54971676
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7688832;
RX   PubMed=9067587;
RX   PubMed=9680106;
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=7688832;
RA   Tatsumi E., Yoneda N., Kawano S., Yamaguchi N.;
RT   "Cytokine in phenotypic analysis of leukemia/lymphoma: suppression of
RT   gene expression of myeloperoxidase by IFN-gamma and subset of AML M1
RT   defined by CD45RO+/RA-, CD7(-), CD34(-) and non-inducible HLA-DR
RT   antigen.";
RL   Rinsho Byori 41:377-383(1993).
//
RX   PubMed=9067587; DOI=10.1038/sj.leu.2400571;
RA   Uphoff C.C., MacLeod R.A.F., Denkmann S.A., Golub T.R., Borkhardt A.,
RA   Janssen J.W.G., Drexler H.G.;
RT   "Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in
RT   human early B-lineage leukemia cell lines.";
RL   Leukemia 11:441-447(1997).
//
RX   PubMed=9680106; DOI=10.1016/S0145-2126(98)00050-2;
RA   Matsuo Y., Drexler H.G.;
RT   "Establishment and characterization of human B cell precursor-leukemia
RT   cell lines.";
RL   Leuk. Res. 22:567-579(1998).
//